SCHEMBL1715480

SCHEMBL1715480

CC1=[N+](CCCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)O)cc2C1(C)CCCCCC(=O)O

nearest known ligand 0.32

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.32
HTR1A P08908 2/20 0.32
ALDH1A1 P00352 2/20 0.31
PARP1 P09874 1/20 0.31
BRD4 O60885 1/20 0.31
TBXA2R P21731 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
CYP26B1 Q9NR63 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15227488 1.00 ADRB2 (0.32) ADRB2HTR1AALDH1A1PARP1BRD4
SCHEMBL11912398 0.94 ALDH1A1 (0.33) ALDH1A1TBXA2RCYP26B1PKM
SCHEMBL12952231 0.93 ADRB2 (0.32) ADRB2HTR1AALDH1A1TBXA2RCYP26B1
SCHEMBL1656937 0.90 ADRB2 (0.33) ADRB2HTR1AALDH1A1PARP1BRD4
SCHEMBL178258 0.90 ALDH1A1 (0.32) ADRB2HTR1AALDH1A1TBXA2RCYP26B1
SCHEMBL559886 0.89 ADRB2 (0.33) ADRB2HTR1AALDH1A1PARP1BRD4
SCHEMBL559885 0.89 ADRB2 (0.33) ADRB2HTR1AALDH1A1PARP1BRD4
SCHEMBL2065361 0.89 ALDH1A1 (0.31) ALDH1A1TBXA2RCYP26B1PKM
SCHEMBL10090478 0.88 PKM (0.35) ALDH1A1TBXA2RPKM
SCHEMBL10090479 0.87 ALDH1A1 (0.35) ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044203-B2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups CARNEGIE MELLON UNIVERSITY (US) 2011-10-25 US disclosed
EP-1525265-B1 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS UNIV CARNEGIE MELLON (US) 2011-07-20 EP disclosed
EP-2258776-A1 Fluorescent cyanine dyes containing functional groups CARNEGIE MELLON UNIVERSITY (US) 2010-12-08 EP disclosed
US-20100267008-A1 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS CARNEGIE MELLON UNIVERSITY (US) 2010-10-21 US disclosed
US-7615646-B2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups CARNEGIE MELLON UNIVERSITY (US) 2009-11-10 US disclosed
US-20060051758-A1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-03-09 US disclosed
EP-1525265-A4 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS UNIV CARNEGIE MELLON (US) 2005-06-22 EP disclosed
EP-1525265-A2 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS CARNEGIE-MELLON UNIVERSITY (US) 2005-04-27 EP disclosed
WO-2004039894-A2 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS CARNEGIE MELLON UNIVERSITY (US) 2004-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060051758-A1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups IDO1, TDO2, IDO2 ADRB2 325/4885HTR1A 118/4885ALDH1A1 1689/4885
US-20100267008-A1 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS IDO1, IDO2, INMT ADRB2 254/4885HTR1A 159/4885ALDH1A1 1629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.